These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28746336)
21. Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's. Bullido MJ; Ramos MC; Ruiz-Gómez A; Tutor AS; Sastre I; Frank A; Coria F; Gil P; Mayor F; Valdivieso F Neurobiol Aging; 2004 Aug; 25(7):853-9. PubMed ID: 15212839 [TBL] [Abstract][Full Text] [Related]
22. Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease. Brodney MA; Johnson DE; Sawant-Basak A; Coffman KJ; Drummond EM; Hudson EL; Fisher KE; Noguchi H; Waizumi N; McDowell LL; Papanikolaou A; Pettersen BA; Schmidt AW; Tseng E; Stutzman-Engwall K; Rubitski DM; Vanase-Frawley MA; Grimwood S J Med Chem; 2012 Nov; 55(21):9240-54. PubMed ID: 22974325 [TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias. Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774 [TBL] [Abstract][Full Text] [Related]
25. Identification of Positive Allosteric Modulators of the D Luderman KD; Conroy JL; Free RB; Southall N; Ferrer M; Sanchez-Soto M; Moritz AE; Willette BKA; Fyfe TJ; Jain P; Titus S; Hazelwood LA; Aubé J; Lane JR; Frankowski KJ; Sibley DR Mol Pharmacol; 2018 Oct; 94(4):1197-1209. PubMed ID: 30068735 [TBL] [Abstract][Full Text] [Related]
26. Beta-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization. Auman JT; Seidler FJ; Slotkin TA Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1236-44. PubMed ID: 12376418 [TBL] [Abstract][Full Text] [Related]
27. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis. Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445 [TBL] [Abstract][Full Text] [Related]
28. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling. Casella I; Ambrosio C; Grò MC; Molinari P; Costa T Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432 [TBL] [Abstract][Full Text] [Related]
31. G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons. Ho JH; Stahl EL; Schmid CL; Scarry SM; Aubé J; Bohn LM Sci Signal; 2018 Aug; 11(542):. PubMed ID: 30087177 [TBL] [Abstract][Full Text] [Related]
32. β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro. Hakalahti AE; Khan H; Vierimaa MM; Pekkala EH; Lackman JJ; Ulvila J; Kerkelä R; Petäjä-Repo UE Mol Pharmacol; 2013 Jan; 83(1):129-41. PubMed ID: 23066091 [TBL] [Abstract][Full Text] [Related]
33. Two serines in the distal C-terminus of the human ß1-adrenoceptor determine ß-arrestin2 recruitment. Hinz L; Ahles A; Ruprecht B; Küster B; Engelhardt S PLoS One; 2017; 12(5):e0176450. PubMed ID: 28472170 [TBL] [Abstract][Full Text] [Related]
34. β-Arrestin-biased signaling mediates memory reconsolidation. Liu X; Ma L; Li HH; Huang B; Li YX; Tao YZ; Ma L Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4483-8. PubMed ID: 25831532 [TBL] [Abstract][Full Text] [Related]
35. A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors. Summerhill S; Stroud T; Nagendra R; Perros-Huguet C; Trevethick M J Pharmacol Toxicol Methods; 2008; 58(3):189-97. PubMed ID: 18652905 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor. Sato T; Baker J; Warne T; Brown GA; Leslie AG; Congreve M; Tate CG Mol Pharmacol; 2015 Dec; 88(6):1024-34. PubMed ID: 26385885 [TBL] [Abstract][Full Text] [Related]
37. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor. Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296 [TBL] [Abstract][Full Text] [Related]